phase readout
saveNCT07432334: CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology. Phase: PHASE1. Conditions: Refractory Systemic Lupus Erythematosus
view source ↗
comments(0)
5-min edit window · permanent after that